Order Article Reprints

Maier FC, Schweifer A, Damaraju VL, Cass CE, Bowden GD, Ehrlichmann W, Kneilling M, Pichler BJ, Hammerschmidt F, Reischl G. 2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging—Investigation of Nucleoside Transporter Interaction, ¹⁸F-Labeling and Preclinical PET Imaging. Pharmaceuticals. 2019; 12(1):31. https://doi.org/10.3390/ph12010031

Maier, Florian C., Anna Schweifer, Vijaya L. Damaraju, Carol E. Cass, Gregory D. Bowden, Walter Ehrlichmann, Manfred Kneilling, Bernd J. Pichler, Friedrich Hammerschmidt, and Gerald Reischl. 2019. "2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging—Investigation of Nucleoside Transporter Interaction, ¹⁸F-Labeling and Preclinical PET Imaging" Pharmaceuticals 12, no. 1: 31. https://doi.org/10.3390/ph12010031

Maier, F. C., Schweifer, A., Damaraju, V. L., Cass, C. E., Bowden, G. D., Ehrlichmann, W., Kneilling, M., Pichler, B. J., Hammerschmidt, F., & Reischl, G. (2019). 2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging—Investigation of Nucleoside Transporter Interaction, ¹⁸F-Labeling and Preclinical PET Imaging. Pharmaceuticals, 12(1), 31. https://doi.org/10.3390/ph12010031